FPHT

(redirected from fosphenytoin)
Also found in: Dictionary, Medical, Wikipedia.
Related to fosphenytoin: Fosphenytoin sodium
AcronymDefinition
FPHTFosphenytoin (drug)
FPHTForest Products Harvest Tax (Oregon)
FPHTFisheries Post-Harvest Technology
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
The Fosphenytoin Sodium Injection USP, 75 mg/ml, (50 mg PE/ml), which have been packaged in 100 mg PE/2 ml and 500 mg PE/10 ml single-use vials, are generic version of Pfizer's Cerebyx Injection.
Multi-center, randomized, double blind trials were designed to determine the most effect and/or least effective treatments of established status epilepticus in a patient older than the age of two years as opposed to comparing fosphenytoin, levetiracetam and valproate.
The choice of a first nonbenzodiazepine drug was fosphenytoin in 52% of cases.
Injections of lorazepam, fosphenytoin, valproic acid, and Phenobarbital were given.
What is the maximum dose of Fosphenytoin that can be given IV on a general unit?
Ltd announced today that they will launch the anticonvulsant agent Fostoin 750 mg for Injection (fosphenytoin sodium hydrate, "fostoin") on January 17.
However, he suffers 1 seizure, which is treated with IV fosphenytoin at the loading dose, 18 mg/kg, then a maintaining dose of 5 mg phenytoin equivalent/kg/d.
Anticonvulsants, These anticonvulsants decrease phenytoin, calcium absorption by increasing the fosphenytoin, metabolism of vitamin D.
The following drugs deplete vitamin D: barbiturates, carbamazepine, cholestyramine, cimetidine, colestipol, corticosteroids, famotidine, fosphenytoin, isoniazid, mineral oil, nizatidine, phenobarbital, phenytoin, ranitidine, and rifampin.
The Food and Drug Administration is investigating preliminary data indicating that people with the human leukocyte antigen (HLA) allele HLA-B*1052 may be at greater risk of developing Stevens-Johnson syndrome and toxic epidermal necrolysis if they receive phenytoin or fosphenytoin.
The Food and Drug Administration is investigating preliminary data indicating that people who have the human leukocyte antigen allele HLA-B*1052 may be at a greater risk of developing Stevens-Johnson syndrome and toxic epidermal necrolysis during treatment with phenytoin or fosphenytoin.
The medication behind the question of limits on intramuscular injection volumes is fosphenytoin (Cerebyx[R]).